Through multiple educational approaches to engage learners in interactive discussion, this program focused on evidence-based methods for addressing obesity and managing its comorbidities in a compassionate manner. This program will be case based and will walk through the lifecycle of a patient with obesity. Faculty will present didactic presentations as well as interact with a standardized patient to emulate interactions one might encounter in a clinic. This symposium is certified for 1.5 AMA PRA Category 1 Credits™ and 1.5 ABIM MOC points.

Target Audience

This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals. 

Learning Objectives

Upon completion of this educational activity, learners will be able to: 

  • Review and identify the available and emerging therapeutic approaches to obesity 
  • Know what’s new in the obesity medicine pipeline 
  • Review different approaches to weight loss/maintenance

Additional Information

Massachusetts Medical Society (MMS)
Course summary
Available credit: 
  • 1.50 MOC
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Course opens: 
Course expires: 
W Timothy Garvey, MD- Program Chair

Department Chair of Nutrition Science 

University of Alabama 

Birmingham, AL 

Sangeeta R. Kashyap, MD 

Assistant Professor of Medicine 

Cleveland Clinic Foundation 

Cleveland, Ohio 

Lisa Neff, MD 

Assistant Professor of Medicine 

Northwestern University 

Chicago, IL 


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. 

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. 

The following faculty reported relevant financial relationships during the content development process for this activity:  

  • W. Timothy Garvey, MD: Research Grant, Sanofi, Pfizer, Novo Nordisk; Advisory Board, Amgen, Gilead, AMGA, BOYDSense, Boehringer-Ingelheim 
  • Lisa M. Neff, MD: Grant, Aegerion Pharmaceuticals; Research Investigator, Novo Nordisk 
  • Sangeeta R. Kashyap, MD: Consultant, GI Dynamics; Research Grant, Ethicon Endo-Surgery 

The following Special Programs Committee member who planned and reviewed content for this activity reported relevant financial relationships:  

  • Amy Rothberg, MD: Advisor, Rhythm Pharmaceuticals; Spouse, consultant of Merck  

The following Special Programs Committee members reported financial relationships: 

  • Andjela T. Drincic, MD: Advisory Board Member, Corcept  
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Esperion, AstraZeneca  
  • Angela M. Leung, MD: Speaker,Medical Education Resources, MCE Conferences  

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following Special Programs Committee members reported no relevant financial relationships: 

  • Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD, Savitha Subramanian, MD;  Soleymani Taraneh, MD; Steven Weitzman, MD 

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™ and 1.5 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to: 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact.

Available Credit

  • 1.50 MOC
  • 1.50 AMA PRA Category 1 Credit
  • 1.50 Participation
Please login or register to take this course.

This course is offered through Endocrine Society. To take this course you will be redirected to Endocrine Society's website. You must have an account with Endocrine Society in order to complete this activity. 

MOCINGBIRD continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!